Rabeprazole and Soy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Soy (soy). Common drug interactions include abdominal pain among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Soy. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Soy?

Soy has active ingredients of soy. eHealthMe is studying from 562 Soy users. Check the latest studies of Soy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

15 people who take Rabeprazole and Soy together, and have interactions are studied.

What are the common drug interactions of Rabeprazole and Soy, by gender? *:

female:

Abdominal pain
C-reactive protein increased
Decreased appetite
Device occlusion
Oedema peripheral (superficial swelling)
Platelet count decreased
White blood cell count decreased
Acute respiratory distress syndrome
Colitis ulcerative (inflammation of colon with ulcer)
Enterococcus test positive

male:

Anaemia (lack of blood)
Drug level increased
Headache (pain in head)
Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
Visual impairment

What are the common drug interactions of Rabeprazole and Soy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Device related infection
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Intestinal haemorrhage (bleeding from intestine)
Overdose

40-49:

Abdominal distension
Device related infection
Nausea (feeling of having an urge to vomit)
Vomiting
Abdominal pain
Device occlusion
Oedema peripheral (superficial swelling)
Pyrexia (fever)
Eyelid oedema (eyelids are swollen and contain excessive fluid)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

50-59:

Anaemia (lack of blood)
Drug level increased
Headache (pain in head)
Visual impairment

60+:

C-reactive protein increased
Decreased appetite
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Staphylococcus test positive
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood bilirubin increased
Fibrin d dimer increased
Gamma-glutamyltransferase increased
Liver disorder (liver diseases)

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 8 people, 53.33%
Liver Disorder (liver diseases): 4 people, 26.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 1 person, 6.67%
Iron Deficiency Anaemia: 1 person, 6.67%
Infection: 1 person, 6.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 6.67%
Fever: 1 person, 6.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 6.67%
Diarrhea: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Soy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously